Form 4: Akero Therapeutics CFO William White Sells Shares to Cover Tax Obligations

Akero Therapeutics' Chief Financial Officer, William Richard White, sold 639 shares of common stock on September 10, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On September 10, 2024, William Richard White, the Chief Financial Officer of Akero Therapeutics, Inc. (AKRO), sold 639 shares of common stock.
• The sale was executed at a price of $26.18 per share.
• This transaction was conducted to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following the transaction, White directly owns 41,152 shares of Akero Therapeutics common stock.
• The sale was automatic under the issuer's 'sell-to-cover' policy and not at the discretion of the reporting person.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (sell-to-cover) by a company executive. It doesn't indicate any significant positive or negative sentiment.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders. This particular transaction appears routine, related to tax obligations.

Stakeholder Impact

• The sale of shares by an insider could have a minor impact on shareholder sentiment, but the reason for the sale (tax obligations) is generally understood and accepted.

Key Dates